Stock Track | Arteris Soars 16.48% on Strong Q3 Results and Upbeat Guidance

Stock Track
Nov 05, 2025

Arteris, Inc. (AIP) stock is soaring 16.48% in Wednesday's trading session following the release of impressive third-quarter results and optimistic future guidance. The system-on-chip (SoC) integration software and IP solutions provider has surpassed analyst expectations, driving significant investor enthusiasm.

The company reported robust Q3 financial results, showcasing an 18% year-over-year revenue growth to $17.40 million, exceeding the consensus estimate of $17 million. Notably, Arteris achieved a record Annual Contract Value (ACV) plus royalties of $74.9 million, marking a substantial 24% increase compared to the previous year. Looking ahead, the company provided an encouraging outlook for Q4, projecting revenue between $18.4 million and $18.8 million, and narrowed its full-year 2025 revenue guidance to $68.8 million - $69.2 million.

Wall Street analysts maintain a positive stance on Arteris stock, with TD Cowen analyst Joshua Buchalter reiterating a Buy rating. The analyst highlighted the company's strong market position and growth potential, particularly noting Arteris' strategic wins and involvement in the rapidly expanding AI sector. The company's focus on expanding partnerships and increasing customer demand in AI and autonomous driving markets appears to be a key factor driving both its financial performance and investor optimism.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10